MedPath

Physiological, Behavioral and Subjective Effects of Drugs (GHB)

Phase 1
Completed
Conditions
Sedative Abuse
Interventions
Registration Number
NCT00058955
Lead Sponsor
Orphan Medical
Brief Summary

The purpose of this study is to learn more about the effects of gamma-hydroxybutyric acid (GHB) by comparing its physiological, behavioral and subjective effects with those of several other drugs.

Detailed Description

The purpose of this study is to learn more about the effects of gamma-hydroxybutyric acid by comparing its physiological, behavioral and subjective effects with those of several other drugs.

This trial will be conducted as a double-blind, double-dummy, placebo-controlled, counter-balanced (Latin-square design) crossover study in volunteers with histories of sedative abuse. Volunteers will be recruited through advertising and word-of-mouth.

Volunteers will reside on our residential research unit for the duration of the study and participate in a maximum of 16 experimental sessions. Sessions will be conducted five days a week (Monday through Friday). The primary subjective and behavioral measures will be taken before drug administration and at 0.5, 1, 2, 3, 4, 6, 8, 12 and 24 hours after drug administration.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
20
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
4sodium oxybate, triazolam and pentobarbitalPlacebo
1sodium oxybate, triazolam and pentobarbitalSodium oxybate
2sodium oxybate, triazolam and pentobarbitaltriazolam
3sodium oxybate, triazolam and pentobarbitalpentobarbital
Primary Outcome Measures
NameTimeMethod
Pharmacokinetics
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Johns Hopkins University School of Medicine/Bayview Medical Center

🇺🇸

Baltimore, Maryland, United States

© Copyright 2025. All Rights Reserved by MedPath